Literature DB >> 21396809

Clinical and radiographic correlates of hypoxemia and oxygen therapy in the COPDGene study.

Deog Kyeom Kim1, Francine L Jacobson, George R Washko, Richard Casaburi, Barry J Make, James D Crapo, Edwin K Silverman, Craig P Hersh.   

Abstract

BACKGROUND: Severe hypoxemia is a major complication of chronic obstructive pulmonary disease (COPD). Long-term oxygen therapy is beneficial in hypoxemic COPD patients. However, the clinical and radiographic predictors of hypoxemia and the use of oxygen therapy are not well described. This study aimed to find the correlates of resting hypoxemia and the pattern of oxygen use in moderate to severe COPD patients.
METHODS: Subjects with GOLD stage II or higher COPD from the first 2500 COPDGene subjects were included in this analysis. All subjects were current or ex-smokers between ages 45 and 80. Severe resting hypoxemia was defined as room air oxygen saturation (SpO(2)) ≤88%. Use of supplemental oxygen therapy was determined by questionnaire.
RESULTS: Eighty-two of 1060 COPD subjects (7.7%) had severe resting hypoxemia. Twenty-one of the 82 (25.6%) were not using continuous supplemental oxygen. Female sex, higher BMI, lower FEV(1), and enrollment in Denver were independent risk factors for hypoxemia; emphysema severity on quantitative chest CT scan did not predict hypoxemia. 132 of 971(13.6%) subjects without severe resting hypoxemia were using continuous supplemental oxygen. In non-hypoxemic oxygen users, Denver recruitment, higher BMI, lower FEV(1), and more severe dyspnea were associated with the use of continuous oxygen.
CONCLUSIONS: A large number of COPD patients without severe hypoxemia were using supplemental oxygen therapy and the pattern of oxygen use was affected by factors other than resting SpO(2) and emphysema severity. Longitudinal data will be required to reveal the effects of oxygen therapy in this subgroup. CLINICAL TRIAL REGISTRATION: http://clinicaltrials.gov (NCT00608764).
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21396809      PMCID: PMC3116986          DOI: 10.1016/j.rmed.2011.02.015

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  27 in total

1.  The St George's Respiratory Questionnaire.

Authors:  P W Jones; F H Quirk; C M Baveystock
Journal:  Respir Med       Date:  1991-09       Impact factor: 3.415

2.  Relationship between exercise capacity and the severity of emphysema as determined by high resolution CT.

Authors:  K Wakayama; N Kurihara; S Fujimoto; M Hata; T Takeda
Journal:  Eur Respir J       Date:  1993-10       Impact factor: 16.671

3.  Chronic obstructive pulmonary disease mortality. A role for altitude.

Authors:  T R Coté; D F Stroup; D M Dwyer; J M Horan; D E Peterson
Journal:  Chest       Date:  1993-04       Impact factor: 9.410

4.  The relation of body mass index to asthma, chronic bronchitis, and emphysema.

Authors:  Stefano Guerra; Duane L Sherrill; Arnel Bobadilla; Fernando D Martinez; Robert A Barbee
Journal:  Chest       Date:  2002-10       Impact factor: 9.410

5.  Lung CT density correlates with measurements of airflow limitation and the diffusing capacity.

Authors:  G A Gould; A T Redpath; M Ryan; P M Warren; J J Best; D C Flenley; W MacNee
Journal:  Eur Respir J       Date:  1991-02       Impact factor: 16.671

6.  Body mass index and the risk of COPD.

Authors:  Raida I Harik-Khan; Jerome L Fleg; Robert A Wise
Journal:  Chest       Date:  2002-02       Impact factor: 9.410

7.  Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party.

Authors: 
Journal:  Lancet       Date:  1981-03-28       Impact factor: 79.321

8.  Time to equilibration of oxygen saturation using pulse oximetry.

Authors:  P Gruber; T Kwiatkowski; R Silverman; E Flaster; C Auerbach
Journal:  Acad Emerg Med       Date:  1995-09       Impact factor: 3.451

9.  Lung volumes in healthy nonsmoking adults.

Authors:  R O Crapo; A H Morris; P D Clayton; C R Nixon
Journal:  Bull Eur Physiopathol Respir       Date:  1982 May-Jun

10.  Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group.

Authors: 
Journal:  Ann Intern Med       Date:  1980-09       Impact factor: 25.391

View more
  22 in total

1.  Quantitative CT Measures of Bronchiectasis in Smokers.

Authors:  Alejandro A Diaz; Thomas P Young; Diego J Maselli; Carlos H Martinez; Ritu Gill; Pietro Nardelli; Wei Wang; Gregory L Kinney; John E Hokanson; George R Washko; Raul San Jose Estepar
Journal:  Chest       Date:  2016-11-24       Impact factor: 9.410

2.  Sinogram Affirmed Iterative Reconstruction (SAFIRE) versus weighted filtered back projection (WFBP) effects on quantitative measure in the COPDGene 2 test object.

Authors:  J P Sieren; E A Hoffman; M K Fuld; K S Chan; J Guo; J D Newell
Journal:  Med Phys       Date:  2014-09       Impact factor: 4.071

3.  SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs.

Authors:  Jered P Sieren; John D Newell; R Graham Barr; Eugene R Bleecker; Nathan Burnette; Elizabeth E Carretta; David Couper; Jonathan Goldin; Junfeng Guo; MeiLan K Han; Nadia N Hansel; Richard E Kanner; Ella A Kazerooni; Fernando J Martinez; Stephen Rennard; Prescott G Woodruff; Eric A Hoffman
Journal:  Am J Respir Crit Care Med       Date:  2016-10-01       Impact factor: 21.405

4.  Genomics and response to long-term oxygen therapy in chronic obstructive pulmonary disease.

Authors:  Minseok Seo; Weiliang Qiu; William Bailey; Gerard J Criner; Mark T Dransfield; Anne L Fuhlbrigge; John J Reilly; Mary Beth Scholand; Peter Castaldi; Robert Chase; Margaret Parker; Aabida Saferali; Jeong H Yun; James D Crapo; Michael H Cho; Terri H Beaty; Edwin K Silverman; Craig P Hersh
Journal:  J Mol Med (Berl)       Date:  2018-10-23       Impact factor: 4.599

5.  Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction.

Authors:  Surya P Bhatt; Jessica C Sieren; Mark T Dransfield; George R Washko; John D Newell; Douglas S Stinson; Gideon K D Zamba; Eric A Hoffman
Journal:  Thorax       Date:  2013-03-23       Impact factor: 9.139

6.  Assessment of two immunodepletion methods: off-target effects and variations in immunodepletion efficiency may confound plasma proteomics.

Authors:  Bhavinkumar B Patel; Carlos A Barrero; Alan Braverman; Phillip D Kim; Kelly A Jones; Dian Er Chen; Russell P Bowler; Salim Merali; Steven G Kelsen; Anthony T Yeung
Journal:  J Proteome Res       Date:  2012-10-29       Impact factor: 4.466

7.  Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional study.

Authors:  Merry-Lynn N McDonald; Alejandro A Diaz; James C Ross; Raul San Jose Estepar; Linfu Zhou; Elizabeth A Regan; Eric Eckbo; Nina Muralidhar; Carolyn E Come; Michael H Cho; Craig P Hersh; Christoph Lange; Emiel Wouters; Richard H Casaburi; Harvey O Coxson; William Macnee; Stephen I Rennard; David A Lomas; Alvar Agusti; Bartolome R Celli; Jennifer L Black-Shinn; Greg L Kinney; Sharon M Lutz; John E Hokanson; Edwin K Silverman; George R Washko
Journal:  Ann Am Thorac Soc       Date:  2014-03

8.  Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease.

Authors:  Merry-Lynn N McDonald; Michael H Cho; Inga-Cecilie Sørheim; Sharon M Lutz; Peter J Castaldi; David A Lomas; Harvey O Coxson; Lisa D Edwards; William MacNee; Jørgen Vestbo; Julie C Yates; Alvar Agusti; Peter M A Calverley; Bartolome Celli; Courtney Crim; Stephen I Rennard; Emiel F M Wouters; Per Bakke; Ruth Tal-Singer; Bruce E Miller; Amund Gulsvik; Richard Casaburi; J Michael Wells; Elizabeth A Regan; Barry J Make; John E Hokanson; Christoph Lange; James D Crapo; Terri H Beaty; Edwin K Silverman; Craig P Hersh
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

9.  Secondary polycythemia in chronic obstructive pulmonary disease: prevalence and risk factors.

Authors:  Michael H Cho; Brian D Hobbs; Jingzhou Zhang; Dawn L DeMeo; Edwin K Silverman; Barry J Make; R Chad Wade; J Michael Wells
Journal:  BMC Pulm Med       Date:  2021-07-14       Impact factor: 3.320

10.  Paired inspiratory-expiratory chest CT scans to assess for small airways disease in COPD.

Authors:  Craig P Hersh; George R Washko; Raúl San José Estépar; Sharon Lutz; Paul J Friedman; MeiLan K Han; John E Hokanson; Philip F Judy; David A Lynch; Barry J Make; Nathaniel Marchetti; John D Newell; Frank C Sciurba; James D Crapo; Edwin K Silverman
Journal:  Respir Res       Date:  2013-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.